Skip to content

Adapting the FACETS Program to Sickle Cell Disease

Adapting the FACETS Fatigue Management Program to Sickle Cell Disease

Status
Recruiting
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06650813
Acronym
Drépa-FACETS
Enrollment
24
Registered
2024-10-21
Start date
2025-01-10
Completion date
2026-05-02
Last updated
2025-08-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Fatigue Symptom, Sickle Cell Disease

Brief summary

Adaptation of a fatigue management program combining the principles of cognitive-behavioral therapy and energy conservation strategies (FACETS program) for a population of adult patients with sickle cell disease (Drépa-FACETS program).

Interventions

OTHERDrépa-FACETS Program

Drépa-FACETS Program for Sickle Cell Disease

Sponsors

University Hospital, Grenoble
CollaboratorOTHER
University Grenoble Alps
CollaboratorOTHER
Paris Nanterre University
CollaboratorOTHER
Versailles Hospital
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
PREVENTION
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Participant having freely given his oral agreement. * Participant with a major sickle cell syndrome, regardless of genotype (e.g. SS, SC, Sbeta). * Participant with a sufficient command of spoken and written French to take the assessments, complete the questionnaires, follow the program sessions and carry out the home exercises.

Exclusion criteria

* Participant with one or more severe psychiatric pathologies (e.g. severe depression, psychosis) that could interfere with the conduct of the study, in particular the primary and secondary endpoints. * Participants with another chronic pathology causing fatigue. * Participants in vaso-occlusive crisis (VOC) or hospitalization. * Participant under legal protection (guardianship, curatorship, safeguard of justice, deprived of liberty).

Design outcomes

Primary

MeasureTime frameDescription
Feasibility of the FACETS program for adult sickle-cell patientsFrom the enrollment to the end of the protocol visits (10 weeks)Main criterion is assessing feasibility. Composite criterion including three sub-criteria are : 1. Participation rate in the main sessions of the program. This criterion will be met if the participant attends at least 4 of the 6 sessions of the program. 2. Success rate in completing home exercises. This criterion will be met if the participant completes at least 50% of the home exercises assigned at the end of each session. 3. Acquisition of fatigue management skills. This criterion will be met if the participant has been able to implement one of the fatigue management techniques proposed by the Drépa-FACETS program in their daily life. The main criterion for evaluating the feasibility/acceptability of the DrépaFACETS program will be met if 2 of the 3 sub-criteria are met.

Countries

France

Contacts

Primary ContactMichalina DANNOUNE
mdannoune@ght78sud.fr0139638856
Backup ContactDamien OUDIN-DOGLIONI, PhD
damien.oudin-doglioni@univ-grenoble-alpes.fr0476748839

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026